These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2946822)

  • 1. Cardiovascular hypertrophy in spontaneously hypertensive rats.
    Sen S; Tarazi RC
    J Hypertens Suppl; 1986 Oct; 4(3):S123-6. PubMed ID: 2946822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regression of hypertrophy in small resistance vessels.
    Sano T; Tarazi RC
    J Hypertens Suppl; 1985 Dec; 3(3):S489-91. PubMed ID: 2856775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and functional adaptation in the rat myocardium and coronary vascular bed caused by changes in pressure and volume load.
    Friberg P
    Acta Physiol Scand Suppl; 1985; 540():1-47. PubMed ID: 3161269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of cardiac hypertrophy with drug treatment in spontaneously hypertensive rats.
    Ruskoaho H
    Med Biol; 1984; 62(5):263-76. PubMed ID: 6152298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of myocardial hypertrophy in prehypertensive spontaneously hypertensive rats: interaction between adrenergic and nitrosative pathways.
    Cabassi A; Dancelli S; Pattoneri P; Tirabassi G; Quartieri F; Moschini L; Cavazzini S; Maestri R; Lagrasta C; Graiani G; Corradi D; Parenti E; Tedeschi S; Cremaschi E; Coghi P; Vinci S; Fiaccadori E; Borghetti A
    J Hypertens; 2007 Aug; 25(8):1719-30. PubMed ID: 17620971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal left ventricular diastolic compliance after regression of hypertrophy.
    Schraeger JA; Canby CA; Rongish BJ; Kawai M; Tomanek RJ
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):349-57. PubMed ID: 7515976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression of left ventricular hypertrophy and control of hypertension in the spontaneously hypertensive rat (SHR): oxprenolol versus hydrochlorothiazide.
    Idikio H; Fernandez PG; Triggle CR; Kim BK
    Clin Invest Med; 1983; 6(1):43-8. PubMed ID: 6219850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal characteristics of cardiomyocyte hypertrophy in the spontaneously hypertensive rat.
    Bell D; Kelso EJ; Argent CC; Lee GR; Allen AR; McDermott BJ
    Cardiovasc Pathol; 2004; 13(2):71-8. PubMed ID: 15033155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of cardiac collagen phenotypes in hypertensive hypertrophy: role of blood pressure.
    Mukherjee D; Sen S
    J Mol Cell Cardiol; 1993 Feb; 25(2):185-96. PubMed ID: 8474126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluvastatin decreases cardiac fibrosis possibly through regulation of TGF-beta(1)/Smad 7 expression in the spontaneously hypertensive rats.
    Zhai Y; Gao X; Wu Q; Peng L; Lin J; Zuo Z
    Eur J Pharmacol; 2008 Jun; 587(1-3):196-203. PubMed ID: 18430418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catecholamines, blood pressure, renin and myocardial function in the spontaneously hypertensive rat.
    Oparil S; Erinoff L; Cutilletta A
    Clin Sci Mol Med Suppl; 1976 Dec; 3():445s-459s. PubMed ID: 140036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arterial hypertrophy and pressor responsiveness during development of hypertension in spontaneously hypertensive rats.
    Leenen FH; Yuan B; Tsoporis J; Lee RM
    J Hypertens; 1994 Jan; 12(1):23-32. PubMed ID: 7908913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of hydralazine and captopril on the cardiovascular changes in spontaneously hypertensive rats.
    Limas C; Westrum B; Limas CJ
    Am J Pathol; 1984 Dec; 117(3):360-71. PubMed ID: 6391187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors regulating myocardial hypertrophy in hypertension.
    Sen S
    Circulation; 1987 Jan; 75(1 Pt 2):I81-4. PubMed ID: 2947754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive agents that limit ventricular hypertrophy inhibit cardiac expression of insulin-like growth factor-I.
    Donohue TJ; Dworkin LD; Ma J; Lango MN; Catanese VM
    J Investig Med; 1997 Dec; 45(9):584-91. PubMed ID: 9444886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consequences of reversal of hypertensive cardiac hypertrophy by captopril on left ventricular pumping ability and performance.
    Saragoça MA; Cezaretti ML; Bessa AM; Casarini D; Almeida JB; Amorim MP; Ramos OL
    J Hypertens Suppl; 1987 Dec; 5(5):S403-6. PubMed ID: 2965226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension-mediated albuminuria is associated with reduced lysosomal activity in the kidney and the heart.
    Hilliard LM; Russo LM; Comper WD
    Am J Nephrol; 2009; 29(5):454-64. PubMed ID: 19023196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin system.
    Lassila M; Davis BJ; Allen TJ; Burrell LM; Cooper ME; Cao Z
    Clin Sci (Lond); 2003 Apr; 104(4):341-7. PubMed ID: 12653675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoregulation and vascular reserve in the coronary circulation of the spontaneously hypertensive rat.
    Edoute Y; Luscher TF; Rubanyi GM
    J Hypertens Suppl; 1986 Dec; 4(5):S290-2. PubMed ID: 3471908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein synthesis in the hypertrophied heart of spontaneously hypertensive rats and a comparison of the effects of an ACE-inhibitor and a calcium channel antagonist.
    Patel VB; Siddiq T; Richardson PJ; Preedy VR
    Cell Biochem Funct; 1995 Jun; 13(2):111-24. PubMed ID: 7538913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.